Home › Funds › Stonepine Capital Management, LLC › QNRX

Stonepine Capital Management, LLC position in QNRX

QUOIN PHARMACEUTICALS LTD · Health Care

Stonepine Capital Management, LLC reported holding 252,434 shares of QNRX (QUOIN PHARMACEUTICALS LTD) in its Q3 2026 13F filing — a position valued at US$1.2M, representing 0.88% of its reported portfolio and ranking #28 among its reported holdings. Stonepine Capital Management, LLC has disclosed QNRX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)252.43K sh
Reported value held$1.15M
Portfolio Weight0.88%
First reportedQ4 2025
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Stonepine Capital Management, LLC's QNRX position evolved

Stonepine Capital Management, LLC first disclosed a stake in QNRX in Q4 2025 at 78,189 shares (US$1.1M). The position peaked in Q3 2026 at 252,434 shares, worth US$1.2M. Across 4 filings, Stonepine Capital Management, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 252,434 shares valued at US$1.2M — an increase of 52,948 shares quarter over quarter.. Notable position changes include a 32% trim in Q1 2026 (shares fell 27% over the following quarter), a 273% increase in Q2 2026 (shares fell 6% over the following quarter), a 27% increase in Q3 2026 (shares fell 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 78.19K $1.13M New
Q1 2026 53.46K $352.84K Reduce
Q2 2026 199.49K $965.51K Add
Q3 2026 252.43K $1.15M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About QNRX and 13F data

QNRX (QUOIN PHARMACEUTICALS LTD) is a Health Care company. 22 other funds we track also report a position in QNRX — the largest reported positions include AIGH Capital Management LLC (US$1.1M), Dauntless Investment Group, LLC (US$1.0M), Velan Capital Investment Management LP (US$157K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding QNRX

All QNRX fund holders →

FAQ

How long has Stonepine Capital Management, LLC held QNRX?

Stonepine Capital Management, LLC has disclosed QNRX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Stonepine Capital Management, LLC's current position in QNRX?

As of Q3 2026, Stonepine Capital Management, LLC holds 252.43K shares of QNRX (QUOIN PHARMACEUTICALS LTD), valued at $1.15M, representing 0.88% of its reported portfolio and ranking #28.

Has Stonepine Capital Management, LLC been buying or selling QNRX?

In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC increased its position in QNRX. The position peaked in Q3 2026 at 252.43K shares.

Which other funds hold QNRX?

Other major institutional holders of QNRX include AIGH Capital Management LLC, Dauntless Investment Group, LLC, Velan Capital Investment Management LP, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.